Considering the progressive accumulation of genomic abnormalities associated with tumor progression, we wondered if Vk*MYC MM remained dependent on MYC dysregulated expression, which in this model is the driver of progression from monoclonal gammopathy. The gene discussed is MYC; the disease is Miyoshi myopathy.